The role of brain angiotensin II in the mechanism of the pressor responses to intracisternal injection of hypertonic NaCl in urethane anesthetized rats. 1982

K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi

Intracisternal injections of hypertonic NaCl elicited the pressor responses in urethane anesthetized spontaneously hypertensive and normotensive Wistar rats. The intracisternal pretreatment of 1-Sar-8-Ile-angiotensin II, angiotensin II analog, could abolish the pressor responses to intracisternal injections of 5% NaCl in urethane anesthetized spontaneously hypertensive rats, while basal blood pressure was not affected by these pretreatment. Both intracisternal and intravenous administration of captopril, an angiotensin I converting enzyme inhibitor, did not alter the pressor effect of hypertonic NaCl in normotensive rats. Basal blood pressure was lowered by intravenous injection of captopril. The involvement of angiotensin II in the pressor mechanism of hypertonic NaCl was confirmed by the enhanced pressor responses to intracisternal injections of 5% NaCl in urethane anesthetized rats pretreated intracisternally with angiotensin II. These findings suggest that angiotensin II itself could play an important role in the pressor responses to intracisternal injections of hypertonic NaCl without involving a converting enzyme system.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008297 Male Males
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D002946 Cisterna Magna One of three principal openings in the SUBARACHNOID SPACE. They are also known as cerebellomedullary cistern, and collectively as cisterns. Magna, Cisterna
D000758 Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi
January 1989, Archives internationales de pharmacodynamie et de therapie,
K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi
January 1988, Clinical and experimental hypertension. Part A, Theory and practice,
K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi
June 1981, Brain research,
K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi
June 1968, European journal of pharmacology,
K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi
January 2009, Neurourology and urodynamics,
K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi
August 1986, The American journal of physiology,
K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi
February 1999, Sheng li xue bao : [Acta physiologica Sinica],
K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi
May 1983, Brain research,
K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi
April 1980, Brain research,
K Takeda, and H Takahashi, and H Ashizawa, and A Inoue, and R Shikuma, and R Takashina, and M Yoshimura, and M Nakagawa, and H Ijichi
March 1994, American journal of hypertension,
Copied contents to your clipboard!